Rapidly Reversible Hydrophobization: An Approach to High First-Pass Drug Extraction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rapidly Reversible Hydrophobization: An Approach to High First-Pass Drug Extraction

Published:2007-09 Issue:9 Volume:14 Page:1065-1077
ISSN:1074-5521
Container-title:Chemistry & Biology
language:en
Short-container-title:Chemistry & Biology

Author:

Monahan Sean D.,Subbotin Vladimir M.,Budker Vladimir G.,Slattum Paul M.,Neal Zane C.,Herweijer Hans,Wolff Jon A.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,General Medicine,Biochemistry

Reference59 articles.

1. Drug delivery to tumours: recent strategies;Reddy;J. Pharm. Pharmacol.,2005

2. Recent advances in tumor-targeting anticancer drug conjugates;Jaracz;Bioorg. Med. Chem.,2005

3. Recent advances in small molecule drug delivery;Kidane;Curr. Opin. Chem. Biol.,2005

4. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release;Andresen;Prog. Lipid Res.,2005

5. Recent advances with liposomes as pharmaceutical carriers;Torchilin;Nat. Rev. Drug Discov.,2005

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melphalan flufenamide is an Anticancer medication used to treat multiple Myeloma: A Review;Asian Journal of Research in Pharmaceutical Sciences;2021-11-26

2. A hypothesis on paradoxical privileged portal vein metastasis of hepatocellular carcinoma. Can organ evolution shed light on patterns of human pathology, and vice versa?;Medical Hypotheses;2019-05

3. Privileged portal metastasis of hepatocellular carcinoma in light of co-evolution of a visceral portal system and the liver in the chordate lineage: a search for therapeutic targets;Drug Discovery Today;2018-03

4. Loco-regional cancer drug therapy: present approaches and rapidly reversible hydrophobization (RRH) of therapeutic agents as the future direction;Drug Discovery Today;2014-12

5. Dendritic cell-based cancer immunotherapy: the stagnant approach and a theoretical solution;Drug Discovery Today;2014-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3